Personalis to Present at Upcoming Investor Conferences
20 11월 2019 - 6:05AM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, today announced that Aaron Tachibana, Chief Financial
Officer and Clinton Musil, Chief Business Officer, are scheduled to
present at the following upcoming investor conferences.
- Piper Jaffray 31st Annual Healthcare Conference on Wednesday,
December 4, 2019 at 11:30 a.m. Eastern Time at the Lotte New York
Palace Hotel in New York.
- Evercore ISI 2nd Annual HealthCONx Conference on Thursday,
December 5, 2019 at 11:00 a.m. Eastern Time at the Four Seasons
Hotel in Boston.
About Personalis, Inc.
Personalis, Inc. is a growing cancer genomics company
transforming the development of next-generation therapies by
providing more comprehensive molecular data about each patient’s
cancer and immune response. The company’s NeXT™ Platform is
designed to adapt to the complex and evolving understanding of
cancer, providing its biopharmaceutical customers with information
on all of the approximately 20,000 human genes, together with the
immune system, from a single tissue sample. Personalis also
provides genomic information to the VA Million Veterans Program as
part of their goal to sequence over a million veteran genomes. The
Personalis Clinical Laboratory is GxP aligned as well as
CLIA’88-certified and CAP-accredited. For more information, please
visit www.personalis.com and follow Personalis on Twitter
(@PersonalisInc).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191119005053/en/
Investor Relations Contact for Personalis: Caroline
Corner investors@personalis.com 415-202-5678
Media Contact for Personalis: Jennifer Havlek
pr@personalis.com www.personalis.com 650-752-1300
Personalis (NASDAQ:PSNL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Personalis (NASDAQ:PSNL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024